Spironolactone, Metformin, and Bicalutamide for Acne in a 2026 Review: Questions Teens With Inflammatory Acne Can Ask a Dermatologist

Teens with inflammatory acne can ask a dermatologist if spironolactone, metformin, or bicalutamide fits their case. Inflammatory acne means tender red papules, pus-filled pustules, and deep painful nodules or cysts. None of the three drugs is FDA-approved for acne, so standard care usually comes first.

The American Academy of Dermatology gives strong backing to benzoyl peroxide, retinoids, antibiotic combinations, and isotretinoin for severe acne. Hormonal options receive only conditional, case-by-case use. Use lesion pattern, hormone clues, and safety checks to guide the visit.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Do my lesions signal inflammatory acne?
Where do proven treatments fit first?
What should I ask about spironolactone?
What should I ask about metformin?
What should I ask about bicalutamide?

Do my lesions signal inflammatory acne?

The MedlinePlus acne tutorial describes inflammatory lesions as tender red papules, pus-filled pustules, and deep painful nodules or cysts. It separates them from noninflammatory open comedones and closed comedones. Knowing which type dominates changes treatment and follow-up.

Ask which lesions dominate and whether scarring or dark marks are likely. Teens with mixed breakouts still benefit from naming each type. Bring these checks:.

Ask what share is papules, pustules, or nodules versus blackheads or whiteheads.
Ask about personal risk for scars and lingering pigmentation.
Ask what photos or records will track change.

Where do proven treatments fit first?

The American Academy of Dermatology gives strong recommendations to topical benzoyl peroxide, retinoids, antibiotics and combinations, plus oral isotretinoin for severe acne in its updated AAD acne guidance. Hormonal therapies, including combined oral contraceptives or spironolactone, receive only conditional use. That means the dermatologist weighs them case by case.

Ask what standard options fit the severity and history. Prior topicals, combinations, and adherence matter before off-label paths. Ask when isotretinoin enters the discussion for severe or scarring disease.

What should I ask about spironolactone?

A clinician review of dermatology material describes spironolactone as off-label for hormonally influenced acne in females, typically studied at 50-200 mg daily in its clinician review of spironolactone for acne. Ask whether breakouts follow a hormonal pattern. Ask what contraception is required during use.

The DailyMed spironolactone label says the drug retains potassium. It contraindicates use with anuria, acute renal insufficiency, significant renal impairment, hyperkalemia, Addison's disease, or eplerenone use. It also carries animal tumorigenicity warnings. Healthy young women often skip routine potassium checks, while at-risk patients need testing.

Ask about kidney issues, potassium levels, and interacting drugs.
Ask who needs baseline and repeat potassium testing.
Ask about pregnancy planning and follow-up timing.

What should I ask about metformin?

FDA prescribing information approves metformin only for type 2 diabetes in adults and children 10 years and older, not acne. It carries a boxed warning for lactic acidosis. It can cause stomach upset, lower vitamin B12, and must not be used when eGFR is below 30.

A 2019 study in the Journal of Clinical and Aesthetic Dermatology followed 40 women with polycystic ovary syndrome and acne in its 2019 PCOS-acne study summary. Metformin 500 mg three times daily for 8 weeks cut severity scores from about 80.8 to 9.7, p less than 0.001. That supports adjunctive rather than primary use. Ask about PCOS signs, insulin resistance, and diabetes screening.

Ask whether cycle changes, excess hair, or weight clues suggest PCOS evaluation.
Ask what gut, kidney, and B12 monitoring fits.
Ask what primary acne treatment continues alongside it.

What should I ask about bicalutamide?

The FDA bicalutamide label indicates the drug for prostate cancer, not acne, in its FDA bicalutamide label. It reports postmarketing death or hospitalization from severe liver injury. Hepatitis or marked enzyme rises led to stopping treatment in about 1% of trial patients.

It can cause fetal harm if given in pregnancy. A 2025 review in the Journal of Cutaneous and Aesthetic Surgery calls bicalutamide an androgen-receptor antagonist used experimentally in women for hair loss, hirsutism, seborrhea, and acne. It notes mostly mild events but transient liver-enzyme rises needing monitoring. Evidence in teens with acne remains limited.

Ask why bicalutamide is being considered instead of better-studied options.
Ask what liver-test schedule and stop rules apply.
Ask what strict pregnancy prevention is required.